GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED;NATIONAL INSTITUTES OF HEALTH
发明人:
WILFRET, DAVID A.,KEICHER, JESSE DANIEL,ROSENBERG, HELENE FISCHER
申请号:
CA2967039
公开号:
CA2967039A1
申请日:
2015.11.09
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
Aspects of the present invention are related to the use of Lactobacillus species in a composition for respiratory administration to prevent the pathogenic inflammatory sequelae of respiratory virus infections.